Tenaya Therapeutics (TNYA) Other Non Operating Income (2020 - 2025)
Tenaya Therapeutics (TNYA) recorded quarterly Other Non Operating Income of $25000.0 in Q4 2025, up 733.33% quarter-over-quarter from $3000.0 in Q3 2025, and up 525.0% on a YoY basis from $4000.0 in Q4 2024.
Tenaya Therapeutics (TNYA) Other Non Operating Income (2020 - 2025) Analysis & Trends
Tenaya Therapeutics' Other Non Operating Income history runs 6 years deep, the most recent figure standing at $25000.0 for Q4 2025.
- In Q4 2025, Other Non Operating Income rose 525.0% year-over-year to $25000.0; the TTM figure through Dec 2025 stood at $51000.0 (down 37.8% YoY), while the FY2025 annual figure was $52000.0, down 36.59% from the prior year.
- Other Non Operating Income was $25000.0 for Q4 2025 at Tenaya Therapeutics, up from $3000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $82000.0 in Q1 2024 to a low of -$54000.0 in Q4 2021.
- Historically, Other Non Operating Income has averaged $8684.2 across 5 years, with a median of $3000.0 in 2025.
- Biggest YoY gain for Other Non Operating Income was 1600.0% in 2021; the steepest drop was 5300.0% in 2021.
- A 5-year view of Other Non Operating Income shows it stood at -$54000.0 in 2021, then jumped by 94.44% to -$3000.0 in 2022, then jumped by 1466.67% to $41000.0 in 2023, then tumbled by 90.24% to $4000.0 in 2024, then surged by 525.0% to $25000.0 in 2025.
- The last three Other Non Operating Income figures came in at $25000.0 (Q4 2025), $3000.0 (Q3 2025), and -$16000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Tenaya Therapeutics | 158.32 Mn | 158.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | -16,000.00 |
| Mar 31, 2025 | 39,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 82,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -54,000.00 |
| Sep 30, 2021 | 15,000.00 |
| Jun 30, 2021 | 18,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | -1,000.00 |